When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech. Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic cancer, a disease that […]
Aloe Blacc’s fame means nothing in biotech (and that’s the point)
Originally reported by TechCrunch
Related Articles
SpaceX’s Starlink nabs American Airlines contract, another win for its IPO
American Airlines said Tuesday it plans to install Starlink on more than 500 narrow-body Airbus aircraft beginning early...
OpenRouter more than doubles valuation to $1.3B in a year
Popular AI gateway maker OpenRouter, founded in 2023, has raised a hefty $113 million Series B led by CapitalG, the grow...
SpaceX reportedly pressured the Pentagon into paying more for Starlink access
News SpaceX reportedly pressured the Pentagon into paying more for Starlink access Lacking real competition, the compa...
SpaceX's Starlink will soon provide in-flight Wi-Fi for American Airlines
News SpaceX's Starlink will soon provide in-flight Wi-Fi for American Airlines The company has already won contracts w...